Pleiotropic effects of statins on cardiovascular events in the Japanese Coronary Artery Disease study

被引:9
作者
Fujita, Masatoshi [1 ]
Yamazaki, Tsutomu [2 ]
Hayashi, Doubun
Kohro, Takahide
Okada, Yoshihiro
Nagai, Ryozo
机构
[1] Kyoto Univ, Grad Sch Med, Sakyo Ku, Kyoto 6068507, Japan
[2] Univ Tokyo, Dept Clin Epidemiol & Syst, Tokyo, Japan
关键词
cardiovascular events; hydrophilic statins; JCAD study; lipophilic statins; pleiotropic effects;
D O I
10.1016/j.ijcard.2007.06.054
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We analyzed 6317 patients with a baseline LDL-cholesterol level of 70 to 130 mg/dL among 13,812 patients of the Japanese Coronary Artery Disease (JCAD) study. We divided the patients into 2 groups according to statin treatment and its lipophilicity. We compared the incidence of all-cause events between 2000 statin-treated patients and 4317 patients without statins during a median follow-up period of 1092 days (range 0 to 1676 days). After propensity score matching (n = 1641, for each group), Kaplan-Meier analysis showed 25% reduction in the incidence of all-cause events with statin treatment (p = 0.0016). The incidence of all-cause events was also compared between 1139 patients with hydrophilic statin and 861 patients with lipophilic statin. After propensity score matching (n= 778, for each group), Kaplan-Meier analysis showed no significant difference in the incidence of all-cause events with respect to lipophilicity. Subgroup analysis of the JCAD study suggested a lipid-independent beneficial treatment effect of statins on all-cause events, and these favorable effects were comparable between the hydrophilic and lipophilic statins. (C) 2007 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:294 / 296
页数:3
相关论文
共 7 条
[1]   LIPID-LOWERING AND PLAQUE REGRESSION - NEW INSIGHTS INTO PREVENTION OF PLAQUE DISRUPTION AND CLINICAL EVENTS IN CORONARY-DISEASE [J].
BROWN, BG ;
ZHAO, XQ ;
SACCO, DE ;
ALBERS, JJ .
CIRCULATION, 1993, 87 (06) :1781-1791
[2]   Beyond lipid lowering: the role of statins in vascular protection [J].
Liao, JK .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2002, 86 (01) :5-18
[3]  
Nagai R, 2006, CIRC J, V70, P1256
[4]  
Packard CJ, 1998, CIRCULATION, V97, P1440
[5]   EFFECTS OF 3-HYDROXY-3-METHYLGLUTARYL COENZYME-A REDUCTASE INHIBITORS ON MITOCHONDRIAL RESPIRATION IN ISCHEMIC DOG HEARTS [J].
SATOH, K ;
YAMATO, A ;
NAKAI, T ;
HOSHI, K ;
ICHIHARA, K .
BRITISH JOURNAL OF PHARMACOLOGY, 1995, 116 (02) :1894-1898
[6]   Inhibition by simvastatin, but not pravastatin, of glucose-induced cytosolic Ca2+ signalling and insulin secretion due to blockade of L-type Ca2+ channels in rat islet β-cells [J].
Yada, T ;
Nakata, M ;
Shiraishi, T ;
Kakei, M .
BRITISH JOURNAL OF PHARMACOLOGY, 1999, 126 (05) :1205-1213
[7]   Are statins created equal? Evidence from randomized trials of pravastatin, simvastatin, and atorvastatin for cardiovascular disease prevention [J].
Zhou, Z ;
Rahme, E ;
Pilote, L .
AMERICAN HEART JOURNAL, 2006, 151 (02) :273-281